Jakavi 5 MG Tablet
| Brand Name | Jakavi |
|---|---|
| Composition (Generic / INN) | Ruxolitinib |
| Strength | 5 mg |
| Packaging Size | 56 Tablet |
| Packaging Type | Stripe |
| Dosage Form | Tablet |
| Manufacturer | Novartis |
| Usage / Indication | Treat blood disorders (myelofibrosis, polycythemia vera, and graft versus host disease) |
| Minimum Order Quantity | 1 Stripe |
Jakavi 5 MG Tablet contains Ruxolitinib and is manufactured by Novartis. Supplied as a 56-tablet stripe, this oral tablet is indicated for the treatment of certain blood disorders, including myelofibrosis, polycythemia vera, and graft-versus-host disease. It is classified as a targeted oncology therapy and is available for licensed pharmaceutical distribution.
Product Details
- Brand: Jakavi
- Composition: Ruxolitinib
- Strength: 5 mg
- Pack Size: 56 tablets per stripe
- Form: Tablet
- Manufacturer: Novartis
- Minimum Order Quantity: 1 stripe
Export Supply
Gravity Global Export supplies Jakavi 5 MG Tablet to authorized distributors, hospitals, pharmacies, and importers worldwide. We focus on reliable sourcing, proper documentation, and temperature-appropriate logistics for oncology products. All orders are subject to valid import licenses and applicable regulatory requirements in the destination country.
For current availability, pricing, and shipping options, please request a quotation through our team.
Interested in this product?
Tell us your quantity and destination — our export team replies with a competitive quotation.